Roles of ABCA1 in cancer (Review)
- Authors:
- Kun Wu
- Longwei Zou
- Xiaoyong Lei
- Xiaoyan Yang
-
Affiliations: School of Pharmacy, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, P.R. China - Published online on: August 19, 2022 https://doi.org/10.3892/ol.2022.13469
- Article Number: 349
This article is mentioned in:
Abstract
 |
 |
|
Bian X, Liu R, Meng Y, Xing D, Xu D and Lu Z: Lipid metabolism and cancer. J Exp Med. 218:e202016062021. View Article : Google Scholar : PubMed/NCBI | |
|
Chang YC, Lee TS and Chiang AN: Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages. J Lipid Res. 53:1840–1850. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Wang WJ, Zhai L and Zhang DF: Association of cholesterol with risk of pancreatic cancer: A meta-analysis. World J Gastroenterol. 21:3711–3719. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lee BH, Taylor MG, Robinet P, Smith JD, Schweitzer J, Sehayek E, Falzarano SM, Magi-Galluzzi C, Klein EA and Ting AH: Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1. Cancer Res. 73:1211–1218. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Phillips MC: Molecular mechanisms of cellular cholesterol efflux. J Biol Chem. 289:24020–24029. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chushi L, Wei W, Kangkang X, Yongzeng F, Ning X and Xiaolei C: HMGCR is up-regulated in gastric cancer and promotes the growth and migration of the cancer cells. Gene. 587:42–47. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Lokman NA, Noye TM, Macpherson AM, Oehler MK and Ricciardelli C: ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome. Cancer Drug Resist. 4:485–502. 2021.PubMed/NCBI | |
|
Jacobo-Albavera L, Domínguez-Pérez M, Medina-Leyte DJ, González-Garrido A and Villarreal-Molina T: The role of the ATP-binding cassette A1 (ABCA1) in human disease. Int J Mol Sci. 22:15932021. View Article : Google Scholar : PubMed/NCBI | |
|
Luo X, Cheng C, Tan Z, Li N, Tang M, Yang L and Cao Y: Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 16:762017. View Article : Google Scholar : PubMed/NCBI | |
|
Adlakha YK, Khanna S, Singh R, Singh VP, Agrawal A and Saini N: Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis. Cell Death Dis. 4:e7802013. View Article : Google Scholar : PubMed/NCBI | |
|
Yue S, Li J, Lee SY, Lee HJ, Shao T, Song B, Cheng L, Masterson TA, Liu X, Ratliff TL and Cheng JX: Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 19:393–406. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Qiu Z, Yuan W, Chen T, Zhou C, Liu C, Huang Y, Han D and Huang Q: HMGCR positively regulated the growth and migration of glioblastoma cells. Gene. 576:22–27. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ashida S, Kawada C and Inoue K: Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR. Oncol Lett. 14:6533–6542. 2017.PubMed/NCBI | |
|
Xiong T, Xu G, Huang XL, Lu KQ, Xie WQ, Yin K and Tu J: ATP-binding cassette transporter A1: A promising therapy target for prostate cancer. Mol Clin Oncol. 8:9–14. 2018.PubMed/NCBI | |
|
Guo D, Reinitz F, Youssef M, Hong C, Nathanson D, Akhavan D, Kuga D, Amzajerdi AN, Soto H, Zhu S, et al: An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov. 1:442–456. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Touvier M, Fassier P, His M, Norat T, Chan DS, Blacher J, Hercberg S, Galan P, Druesne-Pecollo N and Latino-Martel P: Cholesterol and breast cancer risk: A systematic review and meta-analysis of prospective studies. Br J Nutr. 114:347–357. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou P, Li B, Liu B, Chen T and Xiao J: Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysis. Clin Chim Acta. 477:94–104. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Guillaumond F, Bidaut G, Ouaissi M, Servais S, Gouirand V, Olivares O, Lac S, Borge L, Roques J, Gayet O, et al: Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma. Proc Natl Acad Sci USA. 112:2473–2478. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Menter DG, Ramsauer VP, Harirforoosh S, Chakraborty K, Yang P, His L, Newman RA and Krishnan K: Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites. PLoS One. 6:e288132011. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Gu D, Lee SS, Song B, Bandyopadhyay S, Chen S, Konieczny SF, Ratliff TL, Liu X, Xie J and Cheng JX: Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer. Oncogene. 35:6378–6388. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou T, Zhan J, Fang W, Zhao Y, Yang Y, Hou X, Zhang Z, He X, Zhang Y, Huang Y and Zhang L: Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC). BMC Cancer. 17:2692017. View Article : Google Scholar : PubMed/NCBI | |
|
Cruz PM, Mo H, McConathy WJ, Sabnis N and Lacko AG: The role of cholesterol metabolism and cholesterol transport in carcinogenesis: A review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol. 4:1192013. View Article : Google Scholar : PubMed/NCBI | |
|
Folkerd EJ and Dowsett M: Influence of sex hormones on cancer progression. J Clin Oncol. 28:4038–4044. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Phillips MC: Is ABCA1 a lipid transfer protein? J Lipid Res. 59:749–763. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Saxena K and Shipley GG: Structural studies of detergent-solubilized and vesicle-reconstituted low-density lipoprotein (LDL) receptor. Biochemistry. 36:15940–15948. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Vedhachalam C, Duong PT, Nickel M, Nguyen D, Dhanasekaran P, Saito H, Rothblat GH, Lund-Katz S and Phillips MC: Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J Biol Chem. 282:25123–25130. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Nagao K, Tomioka M and Ueda K: Function and regulation of ABCA1-membrane meso-domain organization and reorganization. FEBS J. 278:3190–3203. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Takahashi Y and Smith JD: Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway. Proc Natl Acad Sci USA. 96:11358–11363. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Lu R, Arakawa R, Ito-Osumi C, Iwamoto N and Yokoyama S: ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation. Arterioscler Thromb Vasc Biol. 28:1820–1824. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D and Chimini G: ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol. 2:399–406. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Landry YD, Denis M, Nandi S, Bell S, Vaughan AM and Zha X: ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions. J Biol Chem. 281:36091–36101. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Santamarina-Fojo S, Remaley AT, Neufeld EB and Brewer HB Jr: Regulation and intracellular trafficking of the ABCA1 transporter. J Lipid Res. 42:1339–1345. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Koseki M, Hirano K, Masuda D, Ikegami C, Tanaka M, Ota A, Sandoval JC, Nakagawa-Toyama Y, Sato SB, Kobayashi T, et al: Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages. J Lipid Res. 48:299–306. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Tang SL, Chen WJ, Yin K, Zhao GJ, Mo ZC, Lv YC, Ouyang XP, Yu XH, Kuang HJ, Jiang ZS, et al: PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway. Atherosclerosis. 222:344–354. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang N, Silver DL, Thiele C and Tall AR: ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem. 276:23742–23747. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Smith JD, Le Goff W, Settle M, Brubaker G, Waelde C, Horwitz A and Oda MN: ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I. J Lipid Res. 45:635–644. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Tall AR: An overview of reverse cholesterol transport. Eur Heart J. 19 (Suppl A):A31–A35. 1998.PubMed/NCBI | |
|
Qian H, Zhao X, Cao P, Lei J, Yan N and Gong X: Structure of the human lipid exporter ABCA1. Cell. 169:1228–1239.e10. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kang MH, Singaraja R and Hayden MR: Adenosine-triphosphate-binding cassette transporter-1 trafficking and function. Trends Cardiovasc Med. 20:41–49. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshioka Y, Sasaki J, Yamamoto M, Saitoh K, Nakaya S and Kubokawa M: Quantitation by (1)H-NMR of dolichol, cholesterol and choline-containing lipids in extracts of normal and phathological thyroid tissue. NMR Biomed. 13:377–383. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Ding X, Zhang W, Li S and Yang H: The role of cholesterol metabolism in cancer. Am J Cancer Res. 9:219–227. 2019.PubMed/NCBI | |
|
Kitahara CM, Berrington de González A, Freedman ND, Huxley R, Mok Y, Jee SH and Samet JM: Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 29:1592–1598. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Huang B, Song BL and Xu C: Cholesterol metabolism in cancer: Mechanisms and therapeutic opportunities. Nat Metab. 2:132–141. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Tabas I: Consequences of cellular cholesterol accumulation: Basic concepts and physiological implications. J Clin Invest. 110:905–911. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Prochazka L, Koudelka S, Dong LF, Stursa J, Goodwin J, Neca J, Slavik J, Ciganek M, Masek J, Kluckova K, et al: Mitochondrial targeting overcomes ABCA1-dependent resistance of lung carcinoma to α-tocopheryl succinate. Apoptosis. 18:286–299. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Schimanski S, Wild PJ, Treeck O, Horn F, Sigruener A, Rudolph C, Blaszyk H, Klinkhammer-Schalke M, Ortmann O, Hartmann A and Schmitz G: Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. Horm Metab Res. 42:102–109. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Dufour J, Viennois E, De Boussac H, Baron S and Lobaccaro JM: Oxysterol receptors, AKT and prostate cancer. Curr Opin Pharmacol. 12:724–728. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Maslyanko M, Harris RD and Mu D: Connecting cholesterol efflux factors to lung cancer biology and therapeutics. Int J Mol Sci. 22:72092021. View Article : Google Scholar : PubMed/NCBI | |
|
Silvente-Poirot S and Poirot M: Cancer. Cholesterol and cancer, in the balance. Science. 343:1445–1446. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Smith B and Land H: Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep. 2:580–590. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Liu K, Zhang W, Tan J, Ma J and Zhao J: MiR-200b-3p functions as an oncogene by targeting ABCA1 in lung adenocarcinoma. Technol Cancer Res Treat. 18:15330338198925902019. View Article : Google Scholar : PubMed/NCBI | |
|
Huang CX, Zhang YL, Wang JF, Jiang JY and Bao JL: MCP-1 impacts RCT by repressing ABCA1, ABCG1, and SR-BI through PI3K/Akt posttranslational regulation in HepG2 cells. J Lipid Res. 54:1231–1240. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Thysell E, Surowiec I, Hörnberg E, Crnalic S, Widmark A, Johansson AI, Stattin P, Bergh A, Moritz T, Antti H and Wikström P: Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol. PLoS One. 5:e141752010. View Article : Google Scholar : PubMed/NCBI | |
|
Murai T, Maruyama Y, Mio K, Nishiyama H, Suga M and Sato C: Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J Biol Chem. 286:1999–2007. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ramprasad OG, Srinivas G, Rao KS, Joshi P, Thiery JP, Dufour S and Pande G: Changes in cholesterol levels in the plasma membrane modulate cell signaling and regulate cell adhesion and migration on fibronectin. Cell Motil Cytoskeleton. 64:199–216. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Plösch T, Gellhaus A, van Straten EM, Wolf N, Huijkman NC, Schmidt M, Dunk CE, Kuipers F and Winterhager E: The liver X receptor (LXR) and its target gene ABCA1 are regulated upon low oxygen in human trophoblast cells: A reason for alterations in preeclampsia? Placenta. 31:910–918. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ohno Y, Ohori M, Nakashima J, Okubo H, Satake N, Hashimoto T and Tachibana M: Association between preoperative serum total cholesterol level and biochemical recurrence in prostate cancer patients who underwent radical prostatectomy. Mol Clin Oncol. 4:1073–1077. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Buchwald H: Cholesterol inhibition, cancer, and chemotherapy. Lancet. 339:1154–1156. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Cerovska E, Elsnerova K, Vaclavikova R and Soucek P: The role of membrane transporters in ovarian cancer chemoresistance and prognosis. Expert Opin Drug Metab Toxicol. 13:741–753. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Amaar YG and Reeves ME: RASSF1C regulates miR-33a and EMT marker gene expression in lung cancer cells. Oncotarget. 10:123–132. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Di Nicolantonio F, Mercer SJ, Knight LA, Gabriel FG, Whitehouse PA, Sharma S, Fernando A, Glaysher S, Di Palma S, Johnson P, et al: Cancer cell adaptation to chemotherapy. BMC Cancer. 5:782005. View Article : Google Scholar : PubMed/NCBI | |
|
Shang Y, Zhang Z, Liu Z, Feng B, Ren G, Li K, Zhou L, Sun Y, Li M, Zhou J, et al: miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1. Oncogene. 33:3267–3276. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer. 2:48–58. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Moitra K: Overcoming multidrug resistance in cancer stem cells. Biomed Res Int. 2015:6357452015. View Article : Google Scholar : PubMed/NCBI | |
|
Bachmeier BE, Iancu CM, Killian PH, Kronski E, Mirisola V, Angelini G, Jochum M, Nerlich AG and Pfeffer U: Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells. Mol Cancer. 8:1292009. View Article : Google Scholar : PubMed/NCBI | |
|
Hou H, Kang Y, Li Y, Zeng Y, Ding G and Shang J: miR-33a expression sensitizes Lgr5+ HCC-CSCs to doxorubicin via ABCA1. Neoplasma. 64:81–91. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Iwasaki H, Okabe T, Takara K, Yoshida Y, Hanashiro K and Oku H: Down-regulation of lipids transporter ABCA1 increases the cytotoxicity of nitidine. Cancer Chemother Pharmacol. 66:953–959. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Sun M, Yang C, Zheng J, Wang M, Chen M, Le DQS, Kjems J and Bünger CE: Enhanced efficacy of chemotherapy for breast cancer stem cells by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense. Acta Biomater. 28:171–182. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JH, Zheng YL, Xu CQ, Gu LZ, Ding ZL, Qin L, Wang Y, Fu R, Wan YF and Hu CP: Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1. Biol Chem. 398:785–792. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ma Y, Li X, Cheng S, Wei W and Li Y: MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1. Mol Med Rep. 11:625–632. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Heilos D, Röhrl C, Pirker C, Englinger B, Baier D, Mohr T, Schwaiger M, Iqbal SM, van Schoonhoven S, Klavins K, et al: Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins. Oncotarget. 9:25661–25680. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wali VB, Bachawal SV and Sylvester PW: Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment. Lipids. 44:925–934. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chen W, Li L, Wang J, Zhang R, Zhang T, Wu Y, Wang S and Xing D: The ABCA1-efferocytosis axis: A new strategy to protect against atherosclerosis. Clin Chim Acta. 518:1–8. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Srivastava N: ATP binding cassette transporter A1-key roles in cellular lipid transport and atherosclerosis. Mol Cell Biochem. 237:155–164. 2002. View Article : Google Scholar : PubMed/NCBI |
